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Short-term outcome analysis of radiofrequency
ablation using ClosurePlus vs ClosureFast
catheters in the treatment of incompetent great
saphenous vein
Joseph Michael R. Zuniga, MD, Anil Hingorani, MD, Enrico Ascher, MD, Alexsander Shiferson, DO,
Daniel Jung, DO, Robert Jimenez, MD, Natalie Marks, MD, RVT, and Thomas McIntyre, RPA-C,
Brooklyn, NY
Background: Radiofrequency ablation (RFA) is a widely accepted alternative to high ligation with proximal stripping of
the great saphenous vein (GSV) in the treatment of lower extremity venous insufficiency. This study compared short-term
outcomes of two generations of (VNUS Closure) RFA catheters, ClosurePlus (CP) and ClosureFast (CF).
Methods: From February 2005 to April 2009, a total of 667 consecutive office-based RFA procedures were performed in our
institution. CP catheters were used in the initial 312 lower extremity cases andCF catheters in the 355 cases that followed. The
technique used for both catheters were as per the manufacturer’s recommendations. Postoperative duplex scans were
completed to document the following endpoints: GSV obliteration; incidence of deep venous thrombosis (DVT); superficial
venous thrombosis (SVT); and presence of loose or floating thrombus proximal to the treated GSV segment.
Results: Of the 667 cases, 98% had available duplex scan studies within 1 week from completion of the procedure.
Complete obliteration of the GSV on duplex scan studies was noted in 98% of 343 cases using the CF catheter and 88%
of 312 cases using the CP catheter (P< .001). No case of DVTwas detected in those treated with the CF catheter, whereas
DVT occurred in 3.5% of cases treated with the CP catheter (P< .001). Incidence of SVT was 10% and 15%, respectively,
for CF and CP (P < .08). Loose thrombus proximal to the GSV was identified in 7% of cases using CF and 6% of cases
using CP (P  .80). No embolic episodes were observed clinically.
Conclusions: CF catheters are superior to CP catheters in terms of GSV obliteration and nonincidence of postoperative
DVT. The absence of DVT may likely be due to the commencement of ablation at 2 cm from the GSV–common femoral
vein junction. (J Vasc Surg 2012;55:1048-51.)
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uCatheter-based endovenous thermal ablation has be-
come a widely accepted, minimally invasive alternative to
the traditional treatment of lower extremity chronic venous
insufficiency that involves high ligation with proximal strip-
ping of the great saphenous vein (GSV). Documented
advantages over the standard surgical management include
minimal postprocedural pain,1,2 faster recovery times,3-5 as
well as the theoretic benefit of a lower recurrence rate
possibly from reduced neovascularization.6
Two rapidly evolving endovenous techniques include
laser ablation and radiofrequency ablation (RFA). The
VNUS Closure System (VNUSMedical Technologies, San
Jose, Calif) is a popular method of endovenous RFA.
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1048ClosurePlus (CP) is an early-generation VNUS RFA
atheter first approved for use in 2003. Several drawbacks
ave been found since its introduction, such as the ex-
ended duration of treatment, complexity of use, as well as
ncidence of both superficial and deep venous thrombosis
DVT) posttreatment.2,6-10 The second-generation Clo-
ureFast (CF) VNUS catheter was introduced in 2006 in an
ffort to resolve these difficulties.11 Due to the new fea-
ures, faster procedure times, and other perceived advan-
ages, CF catheters have been used with increasing fre-
uency. To date, however, no single-center data are
vailable that compare the benefit of using CF over CP
atheters.
The primary purpose of this study was to compare GSV
bliteration after the use of CP andCF catheters. The authors
lso reviewed the incidence of thrombosis in the adjoining
eins, both deep and superficial, as well as the incidence of
oose or floating thrombus proximal to the treated GSV
egment. Comparison of postprocedural pain, recovery
ime, cost, and long-term patient follow-up were beyond
he scope of this study.
ETHODS
Patient population. Six hundred sixty-seven consec-
tive RFA office procedures were performed from February
005 to April 2009, initially using CP catheters for the first
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Volume 55, Number 4 Zuniga et al 1049312 lower extremity cases than CF catheters for the subse-
quent 355 cases. The CEAP classification of the patient’s
venous disease in each group is noted in Table I.
Procedure. The technique used in performing RFA of
the GSV in this study meticulously followed the steps
recommended by the manufacturer for both catheters.
Before the procedure, diluted lidocaine was injected sub-
cutaneously as tumescent anesthesia. Amount of tumescent
anesthesia varied as required by the patient’s body habitus.
For all cases using the CP system, ablation was begun 1 cm
below the GSV-common femoral vein (CFV) junction.
Heparinized saline solution (5000 U in 500 mL of saline
solution) was infused through the catheter at a rate of one
drop per second. Treatment temperature was maintained at
85°C to 90°C while the catheter was being pulled back.
The pull-back rate was 1 cm/minute for the first 3 cm of
the vein length and then subsequently at 2 to 3 cm/minute.
A completion duplex scan was then performed to assess
patency of the treated GSV, as well as that of the adjacent
deep veins. A woven elastic bandage was then applied to the
leg and thigh and this was left in place for 48 hours in all of
the patients. The patients were encouraged to move their
lower extremities and to walk as soon as possible after the
procedure.
Methods used for the CF system were also as per the
manufacturer. As with the CP catheter, tumescent anesthe-
sia was injected before the procedure. Ablation was begun 2
cm below the GSV-CFV junction. Each 7-cm segment of
GSV was heated with the treatment temperature set at
120°C. Significant modification by our vascular surgery
service from the suggested technique involved heating each
7-cm segment three times. Similar postprocedure protocol,
as with the CP catheter, was then followed.
Follow-up protocol. A standard follow-up protocol
was used. Duplex scan studies were performed on patients
within 7 days postprocedure upon their return to our office
and subsequently at 3 months, 6 months, and 1 year after
the procedure. These were done in the supine position to
determine the following endpoints: patency of the treated
GSV, presence of DVT in the CFV, presence of superficial
venous thrombosis (SVT) in adjoining veins, and presence
of loosely attached or floating thrombus proximal to the
segment of treated GSV.
Obliteration of the GSV was defined as the absence of
Table I. Comparison of CEAP classification for patients
under the ClosurePlus and ClosureFast treatment group
CEAP classification
No. of cases using
ClosurePlus
No. of cases using
ClosureFast
1 1 (0.3%) 0
2 44 (14.1%) 34 (9.6%)
3 85 (27.2%) 109 (30.7%)
4 99 (31.7%) 106 (29.9%)
5 17 (5.5%) 12 (3.4%)
6 66 (21.2%) 94 (26.5%)
Total 312 355vein compressibility and color flow. All GSV determined to ae patent were observed for the presence of reflux. The
FV was also checked for presence of DVT. Adjoining
uperficial veins were assessed for venous thrombosis seen
s engorged, hypoechoic veins on duplex scan.
Patients found to have DVT were prescribed warfarin
aily for 6 months. Those found to have loose thrombi or
oating thrombi not extending to the deep veins were
rescribed clopidogrel daily for 6 weeks. These patients, as
ell as patients with SVT, were observed with weekly
uplex scans until resolution. No evidence of pulmonary
mbolic episodes was detected clinically on all patients in
he study.
Statistical analysis. The 2 test and unpaired t-test
ere used to determine the differences between outcomes
f CP and CF groups for the above-mentioned endpoints.
indings were considered significant if the resulting P 
05. All statistical tests were performed with the WINKS
DA Software (Texasoft, Cedar Hill, Tex).
ESULTS
A total of 667 RFA office procedures were performed
rom February 2005 to April 2009. Of these, 655 cases
98%) had available duplex scan studies completed within 1
eek of the procedure. Three hundred twelve of these cases
ere performed using CP catheters, while the remaining
43 cases used CF catheters. Complete obliteration of the
SV was observed in 98% of the cases using the CF cathe-
ers, whereas only 88% of the cases using CP catheters had
imilar results (P  .001). A summary of results is as noted
n Table II.
The incidence of DVT was statistically significant be-
ween the use of CP and CF catheters. No case of DVT was
oted with use of the CF catheter, whereas 3.5% of cases
sing the CP catheter had DVT (P  .001). In contrast,
ncidence rates of SVT and loose GSV thrombi were not
tatistically significant between CP and CF catheters. SVT
as noted in 10% and 15%, respectively, for CF and CP
atheters (P  .08). Loose or floating/mobile thrombi
ere found in 7% of the cases which used CF catheters and
% of the cases which used CP catheters (P  .8).
ISCUSSION
Early-generation VNUS Closure catheters, including
P, consisted of intraluminally placed bipolar heating
robes which are applied to the vein wall with an operating
emperature of 85°C to 90°C. The procedure entailed the
se of a continuous heparinized saline drip to prevent
hrombus formation on the electrodes during the treat-
ent. The technique of infiltrating subcutaneous tumes-
ent anesthesia was also used to improve contact between
he electrodes and the vein wall, to compress and exsangui-
ate the vein being treated and to protect surrounding
issue against thermal injury. External compression was
onstantly applied while continuous catheter withdrawal
as implemented with a pull-back rate of 2 to 3 cm/
inute, which translated roughly to a treatment time of
bout 18 to 22 minutes for a 45-cm GSV.12
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April 20121050 Zuniga et alThe development of the CF system in 2006 has dealt
with the purported drawbacks of its predecessor, particu-
larly in terms of treatment duration. The newer system uses
a 7-cm coil at the distal end of the catheter, which operates
at a treatment temperature of 120°C. Instead of continu-
ous pull-back, this catheter allowed segmental ablation,
remaining stationary every 7 cm during its 20-second en-
ergy cycle. Treatment time was thus reduced to about 5
minutes for the same 45-cm GSV.12 Tumescent anesthesia
is still recommended for the purposes noted above but the
procedure was made simpler by doing away with the need
for a heparinized saline drip. The new-generation radiofre-
quency generators also made pretreatment impedance
checking unnecessary.
RFA causes vein obliteration through heat-induced
collagen denaturation of the vein wall with consequent
collagen fibril contraction, tissue necrosis, and subsequent
lumen reduction.6,12 Complete GSV obliteration using CP
catheters has been found to be 93.4%8 at 1 week after
treatment,1,8 whereas independent reports using CF cath-
eters have shown occlusion rates as high as 100% during the
first few days post-treatment.11 This is comparable to the
result of this single-center comparison of CP and CF cath-
eters showing 88% and 98% obliteration rates at 1 week
post-treatment, respectively. The difference in tempera-
tures used by the CP and CF systems, as well as the
difference in methods by which this thermal energy is
delivered, is suspected to account for the higher oblitera-
tion rates observed with CF. Our vascular surgery service
took this further by heating each 7-cm segment three times
using the CF catheter.
Thrombus formation has been known to complicate
venous RFA procedures. During the process of heating,
endothelial damage occurs not only in the GSV segment
being treated but also either proximal or distal to that
segment. This predisposes to thrombus formation with
resulting SVT. Another possibility of thrombus formation
is that at the end of the procedure, the lumen of the
proximal aspect of the treated segment may open up, either
from resolution of vasospasm or after resorption of tumes-
cent solution, thereby enabling blood to enter an area of
damaged endothelium and resulting in thrombus forma-
tion. Several earlier reports have described that SVT pro-
duced from the above mechanisms can extend to adjoining
Table II. ClosurePlus and ClosureFast results
ClosurePlus (February
Cases/patients 312/
One-week duplex scan available (cases) 312 (1
Completely obliterated GSV 275 (8
Completely patent GSV 25 (8
Partially obliterated GSV 13 (4
DVT 11 (3
SVT 47 (1
Loosely attached proximal GSV thrombus 20 (6
DVT, Deep venous thrombosis; GSV, great saphenous vein; SVT, superficiavessels and contribute to the development of DVT.8,10,13 this entity has been termed endovenous heat-induced
hrombosis by Kabnick et al during the 18th Annual Meet-
ng of the American Venous Forum in Miami, Florida, in
006.14
DVT in the CFV can also be produced by direct endo-
helial damage during the treatment process. Hence, posi-
ioning the CF catheter tip 2 cm beyond the GSV-CFV
unction, which is 1 cm more than what was followed for
he CP catheter, might have played a role both in minimiz-
ng direct endothelial injury to the CFV and limiting
hrombus extension into the deep veins. In this study, 3.5%
f cases which used the CP catheter developed DVT. No
VT was noted for the cases which used CF catheters.
evelopment of DVT that is not due to these processes
ay be explained by factors such as an undiagnosed hyper-
oagulable state.
Our study admits to several limitations. First, although
e have the largest data collection to date comparing CF
nd CP catheters, the study was not randomized. This is a
etrospective study showing the historic comparison of
esults from the period when CP catheters were predomi-
antly used until the development of the CF catheters and
heir subsequent use in our institution. Therefore, similar-
ty of baseline characteristics between the two groups’
atient population could not be ensured. Next, during the
ntire duration of the study, the same practice was involved
hat consisted of the same set of practitioners. By having the
ame practitioners, however, the learning curve might have
ffected the results. Also, when delivered in an adequate
olume, tumescent anesthesia provides both hydrostatic
hysical compression and pharmaceutical-induced spasm,
hich maximizes RFA ablative effects. It was beyond the
cope of this study to correlate great saphenous obliteration
ates with tumescent volume; we tailored our anesthesia
olume to the requirements of the patient’s habitus. Treat-
ent of the GSV using a CF catheter to heat each 7-cm
egment three times is not part of the manufacturer’s
ecommendations. This might have played a role in im-
roving our results. Comparing the incidence of DVT
sing CP catheters at 1 cm and 2 cm away from the
SV-CFV junction was also beyond this study’s scope.
ast, long-term patient outcomes were not reviewed in this
tudy and short-term outcomes noted were mainly ana-
to April 2007) ClosureFast (May 2007 to April 2009) P value
355/298
343 (97%)
337 (98%) .001
4 (1.2%)
2 (0.6%)
0 .001
35 (10%) .08
25 (7%) .80
us thrombosis.2005
283
00%)
8%)
%)
%)
.5%)
5%)
%)omic.
11
1
1
1
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Volume 55, Number 4 Zuniga et al 1051Despite these limitations, our data suggest the superi-
ority of ClosureFast as opposed to ClosurePlus in terms of
successful GSV obliteration as well as reduced incidence of
postoperative DVT. The decreased incidence of DVT may
likely be due to commencement of the ablation 2 cm from
the GSV-SFV junction.
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